According to IMARC Group's latest research report, titled "Neuroendovascular Coil Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", offers a comprehensive analysis of the industry, which comprises insights on the Neuroendovascular Coil Market Growth. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global neuroendovascular coil market size reached US$ 928.1 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,182.7 Million by 2027, exhibiting a growth rate (CAGR) of 4% during 2022-2027.
Neuroendovascular Coil Market Outlook:
Neuroendovascular coil represents a minimally invasive endovascular treatment procedure that is usually performed to block the blood flow in a blood vessel in the brain and treat an aneurysm. Some of the common symptoms of a ruptured aneurysm generally include sudden onset of a severe headache, vomiting, nausea, blurred vision, seizure, etc. Neuroendovascular coiling is manufactured by using numerous biocompatible metals, including nitinol, platinum, nickel, iridium, tungsten, etc. In this process, a surgeon tightly packs the aneurysm with detachable platinum coils that reduce pressure on the outer wall. It incurs less costs and lowers the risk for the patients. Consequently, neuroendovascular coil finds wide-ranging applications in stroke centers, hospitals, ambulatory surgical centers (ASCs), etc., across the globe.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/neuroendovascular-coil-market/requestsample
Neuroendovascular Coil Market Growth:
The rising improvements in the medical sector are among the key factors stimulating the neuroendovascular coil market. Moreover, the expanding geriatric population, who are more susceptible to developing cerebrovascular disorders, is acting as another significant growth-inducing factor. Besides this, the increasing consumer inclination towards minimally invasive (MI) procedures, such as carotid artery stenting and flow diversion techniques, which offer favorable outcomes and enhanced rehabilitation, is positively influencing the global market. Furthermore, the growing integration of intracranial stents with coil technology to reduce the recurrence of aneurysms is propelling the market growth. Apart from this, the widespread adoption of endovascular coiling, as it is considered a better surgical technique than clipping, is also fueling the global market. Additionally, extensive investments in R&D activities aimed at developing technologically advanced product variants are anticipated to fuel the neuroendovascular coil market over the forecasted period.
Key Market Segmentation:
Competitive Landscape with Key Players:
Medtronic
Stryker Corporation
DePuy Synthes
Penumbra
Johnson & Johnson Services Inc.
Terumo Corporation
Cardinal Health
Boston Scientific Corporation
Cook Medical Incorporated
Balt Extrusion
EndoShape
Breakup by Product Type:
Guglielmi Detachable Coils (GDCs)
Matrix Coils
Breakup by Indication:
Ruptured Aneurysm
Unruptured Aneurysm
Breakup by Application:
Tumor Surgery
Medical Teaching
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers (ASCs)
Stroke Centers
Others
Breakup by Region:
North America (United States, Canada)
Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
Market Performance
Market Outlook
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
Comments